サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1362898

血行動態モニタリングデバイスの市場規模、シェア、動向分析レポート：システムタイプ別、製品別、最終用途別、地域別、セグメント別予測、2023年～2030年

Hemodynamic Monitoring Devices Market Size, Share & Trends Analysis Report, By System Type (Invasive, Minimally Invasive, Non-Invasive), By Product (Disposables, Monitors), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血行動態モニタリングデバイスの市場規模、シェア、動向分析レポート：システムタイプ別、製品別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月05日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血行動態モニタリングデバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の血行動態モニタリングデバイス市場規模は21億8,000万米ドルに達し、2030年までにCAGR 5.2％で拡大すると予測されています。

同市場の成長は、虚血性脳卒中、心不全などの心血管疾患（CVD）の症例が増加していることに起因しています。さらに、世界中で老年人口が増加していることも、血行動態モニタリングデバイスの需要を促進しています。

2021年のOECDの報告書によると、アジアの中低所得国の平均寿命は2000年から6年延び、中所得国の平均寿命は4年延びた。さらに、2050年までにアジア太平洋の10カ国が"高齢化社会"に、11カ国が"超高齢化社会"になると予想されています。さらにNCBIは、CVD患者の半数以上がアジア太平洋地域で記録されていると推定しています。

パンデミックは血行動態モニタリングシステム市場にプラスの影響を与えました。パンデミックの間、COVID-19に誘発された症状により、多くの病院が血行動態モニタリングの需要が高まったと述べています。呼吸器系と循環器系は密接に関連しているため、呼吸器合併症を起こしたCOVID-19患者の心機能と血流をモニターするためには血行動態モニター装置が必要でした。また、敗血症や敗血症性ショックはCOVID-19患者の血行動態を不安定にするため、病院やその他の介護施設では血行動態モニタリングデバイスの使用が必要となっています。

さらに、血行動態モニタリングデバイスの市場は、ベンチャーキャピタルからの資金調達など、さまざまな戦略的イニシアティブによって支えられています。例えば、2022年7月、Retia Medical社はシリーズBで1,500万米ドルの資金提供を受け、商業的提供の拡大とArgos血行動態モニタの開発と商業化を加速させました。

血行動態モニタリングデバイス市場のレポートハイライト

  • ヘルスケア市場の世界市場規模は、2022年に14億7,000万米ドルと推定され、2030年には21億8,000万米ドルに達すると予測されます。
  • 2023年から2030年までの世界市場の複合年間成長率は5.2%と予測されます。
  • 2022年には、北米が41.1％の収益シェアで市場を独占しました。この成長は、大手企業の存在、技術的に進んだヘルスケアエコシステム、重症患者の増加に起因しています。
  • 非侵襲性セグメントは2022年の収益シェアを独占し、市場の55.1％を占めました。
  • 製品別では、モニターが2022年の収益シェア62.7％で市場を独占しました。しかし、ディスポーザブル分野は予測期間中に最も急成長すると予測されます。これは、製品性能の向上と患者ケアの軽減を目的とした大手企業間の協業が拡大しているためです。
  • 病院は、高度なインフラが利用可能で、大手ヘルスケア企業との産業提携があるため、2022年の収益シェアは42.6%で市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血行動態モニタリングデバイス市場の変数、動向、および範囲

  • 市場系統の見通し
  • 市場動向と展望
  • 市場力学
  • 事業環境分析

第4章 血行動態モニタリングデバイス市場：システムタイプのビジネス分析

  • 血行動態モニタリングデバイス市場：システムタイプの動向と市場シェア分析、2022年および2030年
  • 侵襲
  • 低侵襲
  • 非侵襲

第5章 血行動態モニタリングデバイス市場：製品のビジネス分析

  • 血行動態モニタリングデバイス市場：製品の動向と市場シェア分析、2022年および2030年
  • 消耗品
  • モニター

第6章 血行動態モニタリングデバイス市場：最終用途のビジネス分析

  • 血行動態モニタリングデバイス市場：最終用途の動向と市場シェア分析、2022年および2030年
  • 病院
  • カテーテルラボ
  • その他

第7章 血行動態モニタリングデバイス市場：地域のビジネス分析

  • 地域市場のスナップショット
  • 国別の市場シェア分析、2022年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業プロファイル・一覧表
    • Edwards Lifesciences Corporation
    • GE HealthCare
    • Baxter
    • ICU Medical
    • Koninklijke Philips NV
    • Masimo
    • Sramek BioDynamics, Inc.
    • OsypkaCardiotek GmbH
    • Deltex Medical Group
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Hemodynamic Monitoring Devices market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Hemodynamic Monitoring Devices Market: System Type Outlook Key Takeaways
  • Fig. 15 Global Hemodynamic Monitoring Devices Market: System Type Movement Analysis
  • Fig. 16 Global Invasive Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 17 Global Minimally Invasive Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 18 Global Non-Invasive Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Global Hemodynamic Monitoring Devices Market: Product Outlook Key Takeaways
  • Fig. 20 Global Hemodynamic Monitoring Devices Market: Product Movement Analysis
  • Fig. 21 Global Disposables Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Global Monitors Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Global Hemodynamic Monitoring Devices Market: End-use Outlook Key Takeaways
  • Fig. 24 Global Hemodynamic Monitoring Devices Market: End-use Movement Analysis
  • Fig. 25 Global Hospitals Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Global Catheterization Labs Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Global Others Market Estimates and Forecast Market, 2018 - 2030 (USD Billion)
  • Fig. 28 Regional Marketplace: Key Takeaways
  • Fig. 29 Regional outlook, 2022 & 2030
  • Fig. 30 Global Hemodynamic Monitoring Devices Market: Region Movement Analysis
  • Fig. 31 North America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 32 U.S. Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Canada Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Europe Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Germany Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 36 UK Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 37 France Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 38 Italy Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 39 Spain Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 40 Denmark Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Sweden Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Norway Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Asia pacific Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Japan Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 45 China Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 46 India Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 47 Australia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 48 South Korea Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 49 Thailand Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Latin America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 51 Brazil Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 52 Mexico Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 53 Argentina Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 54 Middle East and Africa Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 55 South Africa Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 56 Saudi Arabia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 57 Kuwait Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
  • Fig. 58 UAE Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
目次
Product Code: 978-1-68038-876-3

Hemodynamic Monitoring Devices Market Growth & Trends:

The global hemodynamic monitoring devices market size is expected to reach USD 2.18 billion and expand at a CAGR of 5.2% by 2030, based on a new report by Grand View Research, Inc.. The growth of the market is attributed to the growing cases of cardiovascular diseases (CVD) such as ischemic stroke, heart failure, and others. Moreover, the growing geriatric population across the globe propels the demand for hemodynamic monitoring devices.

According to OECD's report in 2021, the life expectancy in lower-and-middle income Asian countries has increased by six years from 2000, while upper-middle-income countries have recorded a growth of four years in life expectancy. Moreover, by 2050 ten countries in Asia-Pacific are expected to be profiled as "aging societies," while eleven countries are expected to be "super-aged societies." In addition, NCBI estimated that more than half of CVD cases are recorded in the Asia-Pacific region.

The pandemic positively impacted the hemodynamic monitoring systems market. Many hospitals stated increased demand for hemodynamic monitoring during the pandemic due to COVID-19-induced symptoms. Hemodynamic monitoring devices were necessary to monitor cardiac function and blood flow in COVID-19 patients experiencing respiratory complications, as respiratory and cardiovascular systems are closely interconnected. In addition, sepsis & septic shock caused hemodynamic instability in COVID-19 patients; thereby, hemodynamic monitoring devices use was necessitated in hospitals and other care facilities.

In addition, the market for hemodynamic monitoring devices is aided by various strategic initiatives, such as venture capital funding. For instance, in July 2022, Retia Medical received USD 15 million in Series B funding to expand its commercial offerings and accelerate the development & commercialization of Argos hemodynamic monitor.

Hemodynamic Monitoring Devices Market Report Highlights:

  • The global market in the healthcare market size was estimated at USD 1.47 billion in 2022 and is expected to reach USD 2.18 billion in 2030
  • The global market is expected to grow at a compound annual growth rate of 5.2% from 2023 to 2030
  • In 2022, North America dominated the market in terms of the revenue share of 41.1%. This growth can be attributed to the presence of significant players, technologically advanced healthcare ecosystem, and growing number of critically ill patients
  • The non-invasive segment dominated the revenue share in 2022 and accounted for 55.1% in 2022 of the market
  • By product, monitors dominated the market with a revenue share of 62.7% in 2022. However, the disposables segment is estimated to the fastest growing during the forecast period. It is due to the growing collaboration amongst the leading companies to enhance product performance and alleviate patient care
  • Hospitals dominated the market with a revenue share of 42.6% in 2022 due to the availability of advanced infrastructure and industrial partnership with leading healthcare companies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hemodynamic Monitoring Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing critically ill geriatric population
      • 3.3.1.2. Rise in prevalence of cardiac disorders and diabetes
      • 3.3.1.3. Technological advancements
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Complications associated with invasive monitoring
      • 3.3.2.2. Stringent regulatory guidelines for product approvals
  • 3.4. Business Environment Analysis
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Hemodynamic Monitoring Devices Market: System Type Business Analysis

  • 4.1. Hemodynamic Monitoring Devices Market: System Type Movement & Market Share Analysis, 2022 & 2030
  • 4.2. Invasive
    • 4.2.1. Global Invasive Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.3. Minimally Invasive
    • 4.3.1. Global Minimally Invasive Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Non-Invasive
    • 4.4.1. Global Non-Invasive Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Hemodynamic Monitoring Devices Market: Product Business Analysis

  • 5.1. Hemodynamic Monitoring Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 5.2. Disposables
    • 5.2.1. Global Disposables Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.3. Monitors
    • 5.3.1. Global Monitors Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Hemodynamic Monitoring Devices Market: End-Use Business Analysis

  • 6.1. Hemodynamic Monitoring Devices Market: End Use Movement & Market Share Analysis, 2022 & 2030
  • 6.2. Hospitals
    • 6.2.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Catheterization Labs
    • 6.3.1. Global Catheterization Labs Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Others
    • 6.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Hemodynamic Monitoring Devices Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. Market Share Analysis by Country, 2022
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. MEA
  • 7.3. North America
    • 7.3.1. North America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD BILLION)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
    • 7.3.3. Canada
      • 7.3.3.1. Canada Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
  • 7.4. Europe
    • 7.4.1. Europe Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
    • 7.4.2. Germany
      • 7.4.2.1. Germany Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
    • 7.4.3. UK
      • 7.4.3.1. UK Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
    • 7.4.4. France
      • 7.4.4.1. France Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
    • 7.4.5. Italy
      • 7.4.5.1. Italy Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
    • 7.4.6. Spain
      • 7.4.6.1. Spain Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
    • 7.4.7. Denmark
      • 7.4.7.1. Denmark Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
    • 7.4.8. Sweden
      • 7.4.8.1. Sweden Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.8.2. Key Country Dynamics
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5.
    • 7.4.9. Norway
      • 7.4.9.1. Norway Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.4.9.2. Key Country Dynamics
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Regulatory Framework
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
    • 7.5.2. Japan
      • 7.5.2.1. Japan Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
    • 7.5.3. China
      • 7.5.3.1. China Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
    • 7.5.4. India
      • 7.5.4.1. India Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.5.4.2. Key Country Dynamics
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
    • 7.5.5. South Korea
      • 7.5.5.1. South Korea Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.5.5.2. Key Country Dynamics
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
    • 7.5.6. Australia
      • 7.5.6.1. Australia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.5.6.2. Key Country Dynamics
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Regulatory Framework
    • 7.5.7. Thailand
      • 7.5.7.1. Thailand Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.5.7.2. Key Country Dynamics
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Regulatory Framework
  • 7.6. Latin America
    • 7.6.1. Latin America Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
  • 7.7. MEA
    • 7.7.1. MEA Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
    • 7.7.2. South Africa
      • 7.7.2.1. South Africa Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.7.2.2. Key Country Dynamics
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Regulatory Framework
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Saudi Arabia Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.7.3.2. Key Country Dynamics
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Regulatory Framework
      • 7.7.3.5.
    • 7.7.4. UAE
      • 7.7.4.1. UAE Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.7.4.2. Key Country Dynamics
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Regulatory Framework
    • 7.7.5. Kuwait
      • 7.7.5.1. Kuwait Hemodynamic Monitoring Devices Market, 2018 - 2030 (USD Billion)
      • 7.7.5.2. Key Country Dynamics
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. Regulatory Framework

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Profiles/Listing
    • 8.3.1. Edwards Lifesciences Corporation
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. GE HealthCare
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Baxter
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. ICU Medical
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Koninklijke Philips N.V
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Masimo
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Sramek BioDynamics, Inc.
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. OsypkaCardiotek GmbH
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Deltex Medical Group
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives